PhysioStim & Boehringer Ingelheim: choosing the right vascular model

How can you select relevant vascular tissues for your drug candidate? A collaborative study by PhysioStim and Boehringer Ingelheim provides evidence to inform preclinical study design and the interpretation of findings for humans.

Key findings for your study design

Aligning your model with your development objectives

PhysioStim expertise for your vascular studies

Publication reference

Read the publication →

Last News

🫀 World Heart Day | Cardiovascular safety starts long before a drug reaches patients

Vascular safety: the renewed value of ex vivo models in early drug development

Oct 9, 2026

📢 [NEW] IN VITRO HFpEF MODEL – ACCELERATING HEART FAILURE DRUG DISCOVERY

This model was designed by PhysioStim’s research team, leveraging strong expertise in cardiometabolic diseases and human stem cell–based technologies to advance preclinical cardiovascular research.

Jun 26, 2026

📢 [NEW] WHITE PAPER - HEART FAILURE: THE URGENT NEED TO INNOVATE

This review was authored by Bruno Le Grand (PhD), whose deep expertise in cardiovascular pharmacology and extensive experience in the pharmaceutical industry bring both rigor and insight to this work.

Mar 27, 2026

Events

PhysioStim at EUROTOX 2025 – Meet us in Athens!

PhysioStim is proud to take part in EUROTOX 2025, the 59th Congress of the European Societies of Toxicology, as an exhibitor and poster presenter.

Sep 14, 2025 - Sep 17, 2025

PhysioStim at 2025 SPS Annual Meeting – Meet us in Netherlands!

PhysioStim is pleased to participate in the 2025 Safety Pharmacology Society (SPS) Annual Meeting, the premier global event for safety pharmacology professionals.

Oct 13, 2025 - Oct 15, 2025

Replay webinar: Improving HFpEF Modeling: Toward More Predictive Human In Vitro Systems

PhysioStim recently hosted a webinar dedicated to the development of a more predictive human in vitro model for heart failure with preserved ejection fraction (HFpEF). This webinar, led by Lukas Roubenne, PhD, Chief of R&D, and Bruno Le Grand, PhD, CSO, offered the opportunity to present PhysioStim’s latest advances in HFpEF modeling and to share insights into the scientific rationale behind this new approach.

Jun 16, 2026

Tags/Categories

Model

Publication

Collaboration